Smokers hopeful new drug breaks habit
User rating: 4.2 / 5 after 5 vote(s)
Chantix, a new stop-smoking drug that partially activates nicotine receptors in the brain, has arrived on the U.S. market.
Full story »
|
Chantix, a new stop-smoking drug that partially activates nicotine receptors in the brain, has arrived on the U.S. market.
|